Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Bavarian Nordic - Pipeline Update: Flere spændende resultater i vente

By Mie Juel HalseHead of Digital & Events
Bavarian Nordic

Inden for den seneste uge har Bavarian Nordic kunne offentliggøre 12 måneders durability data på deres Covid-19 vaccine samt Fase lll data på deres vaccine mod Chikungunya hos voksne over 65 år. Derudover er der forstærket fokus på Mpox over sommeren, og en forventning om data på vores RSV vaccine senere på sommeren.

Mød og stil spørgsmål til Executive Vice President & CFO, Henrik Juuel den 5. Juli kl. 13.00 når han kommer nærmere ind på de seneste resultater og pipeline.

Du kan allerede nu sende spørgsmål ind.

Disclaimer: HC Andersen Capital modtager betaling fra Bavarian Nordic for en Digital IR aftale. /Claus Thestrup kl. 15.47 26/06/2023.

Recent videos

Gubra – Presentation of Phase 1 Topline Results on ABBV-295 long-acting amylin analog
10.03.2026 klo 14.30 Gubra
Hanza, Capital Markets Day, CMD, 2026
10.03.2026 klo 14.00 HANZA
Scanfil Q4’25: Horizontal operational progress
09.03.2026 klo 11.26 Scanfil
Aiforia, Webcast, H2, 2025
06.03.2026 klo 10.00 Aiforia Technologies
Nightingale, Webcast, Half-year financial report 1 July–31 December 2025
05.03.2026 klo 14.00 Nightingale Health
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.